HOME >> BIOLOGY >> NEWS
Oral ZYVOX shows cost savings for outpatient treatment of skin, other infections vs. vancomycin

SAN FRANCISCO, October 7, 2005 Oral ZYVOX (linezolid) was associated with significant savings to the health care system an average of $4,630 per patient compared to vancomycin when used in an outpatient setting for people with certain infections, according to data to be presented today at the Infectious Diseases Society of America (IDSA) annual meeting. In the study, patients taking oral ZYVOX had fewer physician office visits, emergency room visits, hospitalizations, lab tests and other health care services, as well as lower total costs, compared to patients taking vancomycin.

The study retrospectively analyzed longitudinal claims data from more than 80 health plans for patients treated with ZYVOX or vancomycin on an outpatient basis for infections of which approximately half (48 percent) were skin infections. The average total cost per patient, including drug acquisition and administration as well as all related medical expenses, was 34 percent less for patients who were treated with oral ZYVOX compared with patients who were treated with vancomycin, which must be taken intravenously. ZYVOX is available in interchangeable IV and oral formulations.

"This new information broadens our understanding of the benefits of oral linezolid," said Peggy S. McKinnon, PharmD, Clinical Pharmacist, Transplant Infectious Diseases/Clinical Research at the Barnes-Jewish Hospital in St. Louis, Mo. and lead investigator. "Using an oral agent eliminates the risk of IV complications, such as line infections, as well as the cost of IV administration. This study offers further evidence of the cost savings of oral linezolid to the health care system."

Study Background

McKinnon and other investigators conducted a retrospective study using claims data from more than 80 health care plans to evaluate the impact of outpatient treatment with oral ZYVOX versus IV vancomycin on resource utilization and direct medical costs. The study analyzed 1,048 adul
'"/>

Contact: Jeanne Traflet
212-733-0127
Edelman Public Relations
7-Oct-2005


Page: 1 2

Related biology news :

1. Clones on task serve greater good, evolutionary study shows
2. Research shows skeleton to be endocrine organ
3. An early ape shows its hand
4. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
5. Huntingtons disease study shows animal models on target
6. Research shows NPD1 protects a key component of vision
7. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
8. Chitin from lobster shell shows great healing and bio-stimulant properties
9. Study shows cane sugar, corn sweeteners have similar effects on appetite
10. New research shows vaginal bacteria vary among healthy women, need customized treatment
11. Global warming is evaporating Arctic ponds, new study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... June 02, 2020 , ... ... RFID labeling software developer and solutions provider, today reported that the implementation ... accuracy and compliance by 100%, resulting in greater efficiency for global biotechnology ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... today that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: ... Annual Meeting which will take place virtually on May 29th, 2020. Dr. Benedito ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which takes ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 12, 2020 , ... ... as the new distribution partner for all personal care ingredients in Russia and ... and DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product ...
(Date:5/14/2020)... ... May 13, 2020 , ... ... Future Lab: Optimizing Workflows in the Life Science Lab . The comprehensive ... their lab, from water purification and liquid handling to contamination control. , The ...
(Date:5/9/2020)... ... May 08, 2020 , ... Worldwide Business with kathy ireland® ... program on Sunday, May 10, 2020 and Wednesday, May 13, 2020 at 8:00pm ET ... interviews will spotlight key executives from Techolution and Bravado Pharmaceuticals . ...
(Date:5/5/2020)... ... 2020 , ... ProductLife Group has marked the next phase in ... after 13 years at Altran, where he was Group VP of Life Sciences and ... a Pharmacist, Xavier was involved in his early career in the development of new ...
Breaking Biology Technology:
Cached News: